Comparison of patient-reported outcomes with quetiapine extended release and quetiapine immediate release in patients with stable schizophrenia - the eXtRa Study

被引：0
|
作者：
Riedel, M. [1 ]
Schmitz, M. [2 ]
Ostergaard, P. Kare
Ferrannini, L. [3 ]
Franco, M. A. [4 ]
Alfano, V. [5 ]
Vansvik, E. Dencker [6 ]
机构：
[1] Vinzenz von Paul Hosp, Rottweil, Germany
[2] Inst Psychosomat Med, Psychiatrist Off, Vienna, Austria
[3] ASL3, Dept Mental Hlth & Addict, Genoa, Italy
[4] Zamora Hosp, Dept Psychiat, Zamora, Spain
[5] Parthenope Univ, Dept Studies Inst & Territorial Syst, Naples, Italy
[6] AstraZeneca, Sodertalje, Sweden
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2012年 / 22卷
关键词：
D O I：
10.1016/S0924-977X(12)70523-0
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S339 / S339
页数：1
相关论文
共 50 条
  • [11] Extended-release quetiapine overdose is associated with delayed onset of toxicity compared to immediate-release quetiapine overdose
    Taylor, Lucy
    Graudins, Andis
    EMERGENCY MEDICINE AUSTRALASIA, 2019, 31 (04) : 562 - 568
  • [12] The management of schizophrenia: focus on extended-release quetiapine fumarate
    Peuskens, Joseph
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2011, 7 : 549 - 564
  • [13] Update on extended release quetiapine fumarate in schizophrenia and bipolar disorders
    El-Khalili, Nizar
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2012, 8 : 523 - 536
  • [14] COST AND USE OF RESOURCES IN PATIENTS WITH SCHIZOPHRENIA AND BIPOLAR DISORDER SWITCHING FROM IMMEDIATE RELEASE QUETIAPINE (QTP-IR) TO EXTENDED RELEASE QUETIAPINE (QTP-XR) IN ITALY-THE IBIS STUDY
    Degli Esposti, L.
    La Tour, F.
    Mencacci, C.
    Montagnani, G.
    Pasina, C.
    Sangiorgi, D.
    Spina, E.
    VALUE IN HEALTH, 2012, 15 (04) : A86 - A86
  • [15] Safety of quetiapine fumarate extended release in the treatment of Korean patients with acute schizophrenia
    Lee, Jung-Goo
    Lee, Jong-Il
    Kim, Yang-Tae
    Kim, Chul-Eung
    Kim, Chang-Yoon
    Yoon, Jin-Sang
    Yoo, So-Young
    Kim, Young-Hoon
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2012, 27 (04) : 403 - 410
  • [16] Quetiapine extended-release versus immediate-release formulation: A positron emission tomography study
    Mamo, David C.
    Uchida, Hiroyuki
    Vitcu, Irina
    Barsoum, Penny
    Gendron, Alain
    Goldstein, Jeffrey
    Kapur, Shitij
    JOURNAL OF CLINICAL PSYCHIATRY, 2008, 69 (01) : 81 - 86
  • [17] Differential use of extended and immediate release quetiapine: a retrospective registry study of Finnish inpatients with schizophrenia spectrum and bipolar disorders
    Hallinen, Taru
    Soini, Erkki J.
    Granstrom, Ola
    Ovaskainen, Yrjo
    Leinonen, Esa
    Koponen, Hannu J.
    Hanninen, Kari
    BMJ OPEN, 2012, 2 (04):
  • [18] Pharmacokinetics and Tolerability of Extended-Release Quetiapine Fumarate in Han Chinese Patients with Schizophrenia
    Qian Li
    Yun Ai Su
    Yi Liu
    Jing Xu Chen
    Yun Long Tan
    Fu De Yang
    Tian Mei Si
    Clinical Pharmacokinetics, 2014, 53 : 455 - 465
  • [19] Pharmacokinetics and Tolerability of Extended-Release Quetiapine Fumarate in Han Chinese Patients with Schizophrenia
    Li, Qian
    Su, Yun Ai
    Liu, Yi
    Chen, Jing Xu
    Tan, Yun Long
    Yang, Fu De
    Si, Tian Mei
    CLINICAL PHARMACOKINETICS, 2014, 53 (05) : 455 - 465
  • [20] Efficacy, tolerability, compliance, and quality of life of patients with mood disorders switched from Quetiapine immediate release to extended release
    Dell'Osso, Bernardo
    Arici, Chiara
    Dobrea, Cristina
    Benatti, Beatrice
    Altamura, A. Carlo
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2012, 27 (06) : 310 - 313
12345